|
Improving Access to
Breast Cancer Clinical Trials
Imaging:
Positron
Emission Tomography Before Surgery in Evaluating Women With Primary
or Recurrent Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; recurrent
breast cancer
Magnetic
Resonance Imaging in Women Receiving Chemotherapy for Stage III
Breast Cancer
Conditions: stage IIIA breast cancer; stage IIIB breast cancer;
stage IIIC breast cancer
The
goals of Study 6657 are to investigate the validity of breast MRI
as a staging tool for patients undergoing neoadjuvant chemotherapy
and to quantify early responses to therapy using MRI measurements
of volume and contrast kinetics.
New York; Memorial Sloan-Kettering Cancer Center
Pilot
Diagnostic Study of Fludeoxyglucose F 18 Positron Emission Tomography
for Preoperative Evaluation of Women With Primary or Recurrent Breast
Cancer
Diagnostic
Study of Contrast-Enhanced Magnetic Resonance Imaging and Correlative
Molecular Studies in Women With Locally Advanced Breast Cancer Who
Are Receiving Neoadjuvant Chemotherapy
Use
of Breast MRI & Biomarker Studies to Characterize Tumor Response
in Patients Receiving Neoadjuvant Treatment for Locally Advanced
Breast Cancer
Contrast-Enhanced
Breast MRI Evaluation of Patients Undergoing Neoadjuvant Treatment
for Locally Advanced Breast Cancer
Rapid
Magnetic Resonance Imaging (MRI) of the Hematopoietic System
Source: http://www.cancer.gov/ClinicalTrials/,
http://www.centerwatch.org,
http://www.Clinicaltrials.gov
If you are
interested in participating in a Breast Cancer Clinical Trial call
CDN at: (212) 382-0699, ext. 227.
Treatment
Chemotherapy
Homeopathic
Lymph Node Removal
Other Treatments: Pharmaceutical
Radiation Therapy
Treatment Drugs
Prevention
& Screening & Diagnostic
Imaging
Mammography
Prevention of Breast Cancer
Postmenopausal/ Older Women Patients
Genetics
Genetic trials
Quality
of Life/ Supportive Care
Support
Groups for Heterosexual Women with Breast Cancer & Lesbian Women
with Breast Cancer
|
